Nektar Therapeutics | NKTR - Sales Revenues


Nektar Therapeutics reported $24.12M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Agios Pharmaceuticals USD 19.97M 7.07M Dec/2025
ALKERMES USD 384.5M 9.7M Dec/2025
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Amgen USD 9.9B 340M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
BioCryst Pharmaceuticals USD -86.95M 204.03M Dec/2024
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Eisai JPY 219.94B 22.58B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Exelixis USD 598.66M 860K Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.34B 159.69M Mar/2026
Halozyme Therapeutics USD 451.76M 97.76M Dec/2025
Incyte USD 1.51B 140M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
Ironwood Pharmaceuticals USD 47.71M 74.35M Dec/2025
Karyopharm Therapeutics USD 30.54M 8.24M Dec/2024
MacroGenics USD 72.84M 50.6M Sep/2025
Merck USD 16.4B 880M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Neurocrine Biosciences USD 805.5M 10.6M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sarepta Therapeutics USD 442.9M 43.5M Dec/2025
Takeda JPY 1.19T 80B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
Xencor USD 28.24M 7.24M Dec/2025